Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/2/2025

Tramadol and Celecoxib Combination Therapy

Introduction to Combination Therapy

  • The American Geriatrics Society recommends starting tramadol at 12.5-25 mg every 4-6 hours in older adults or those with comorbidities, with careful monitoring for opioid side effects including drowsiness, constipation, and nausea 1
  • The American Academy of Family Physicians suggests celecoxib typical dosing is 100-200 mg twice daily for pain management 2

Dosing Considerations

  • For patients with hepatic impairment, tramadol dosing must be reduced to no more than 50 mg within 12 hours due to 2-3 fold increased bioavailability, as recommended by Clinical and Molecular Hepatology 3

Safety Precautions

  • The American Geriatrics Society warns of the risk of seizures with tramadol, particularly at high doses or in predisposed patients 1
  • The American Academy of Family Physicians advises avoiding celecoxib in patients at risk for cardiovascular events, as COX-2 inhibitors increase cardiac ischemic events by approximately 3.5 per 1,000 persons compared to placebo 2
  • The American Heart Association recommends avoiding celecoxib in patients with congestive heart failure or hypertension, as NSAIDs can worsen these conditions and increase blood pressure by a mean of 5 mm Hg 5
  • The American Academy of Family Physicians notes that celecoxib increases GI bleeding risk, though less than non-selective NSAIDs, and considers adding a PPI in high-risk patients (age >75, history of GI bleeding, concurrent anticoagulants) 2

Special Population Considerations

  • Clinical and Molecular Hepatology recommends limiting tramadol to 50 mg every 12 hours maximum in patients with liver cirrhosis, due to increased bioavailability 3
  • The American Association for the Study of Liver Diseases advises avoiding NSAIDs, including celecoxib, in cirrhotic patients due to risks of nephrotoxicity, GI bleeding, and hepatic decompensation 3
  • The American Geriatrics Society suggests starting with the lowest effective doses and monitoring closely for CNS effects and renal function in elderly patients 1